339 related articles for article (PubMed ID: 19592466)
1. Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus.
Jarinova O; Stewart AF; Roberts R; Wells G; Lau P; Naing T; Buerki C; McLean BW; Cook RC; Parker JS; McPherson R
Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1671-7. PubMed ID: 19592466
[TBL] [Abstract][Full Text] [Related]
2. ANRIL expression is associated with atherosclerosis risk at chromosome 9p21.
Holdt LM; Beutner F; Scholz M; Gielen S; Gäbel G; Bergert H; Schuler G; Thiery J; Teupser D
Arterioscler Thromb Vasc Biol; 2010 Mar; 30(3):620-7. PubMed ID: 20056914
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B.
Congrains A; Kamide K; Oguro R; Yasuda O; Miyata K; Yamamoto E; Kawai T; Kusunoki H; Yamamoto H; Takeya Y; Yamamoto K; Onishi M; Sugimoto K; Katsuya T; Awata N; Ikebe K; Gondo Y; Oike Y; Ohishi M; Rakugi H
Atherosclerosis; 2012 Feb; 220(2):449-55. PubMed ID: 22178423
[TBL] [Abstract][Full Text] [Related]
4. Interferon-γ activates expression of p15 and p16 regardless of 9p21.3 coronary artery disease risk genotype.
Almontashiri NA; Fan M; Cheng BL; Chen HH; Roberts R; Stewart AF
J Am Coll Cardiol; 2013 Jan; 61(2):143-7. PubMed ID: 23199516
[TBL] [Abstract][Full Text] [Related]
5. The myocardial infarction associated CDKN2A/CDKN2B locus on chromosome 9p21 is associated with stroke independently of coronary events in patients with hypertension.
Wahlstrand B; Orho-Melander M; Delling L; Kjeldsen S; Narkiewicz K; Almgren P; Hedner T; Melander O
J Hypertens; 2009 Apr; 27(4):769-73. PubMed ID: 19293724
[TBL] [Abstract][Full Text] [Related]
6. 9p21.3 Coronary Artery Disease Risk Variants Disrupt TEAD Transcription Factor-Dependent Transforming Growth Factor β Regulation of p16 Expression in Human Aortic Smooth Muscle Cells.
Almontashiri NA; Antoine D; Zhou X; Vilmundarson RO; Zhang SX; Hao KN; Chen HH; Stewart AF
Circulation; 2015 Nov; 132(21):1969-78. PubMed ID: 26487755
[TBL] [Abstract][Full Text] [Related]
7. Functional analyses of coronary artery disease associated variation on chromosome 9p21 in vascular smooth muscle cells.
Motterle A; Pu X; Wood H; Xiao Q; Gor S; Ng FL; Chan K; Cross F; Shohreh B; Poston RN; Tucker AT; Caulfield MJ; Ye S
Hum Mol Genet; 2012 Sep; 21(18):4021-9. PubMed ID: 22706276
[TBL] [Abstract][Full Text] [Related]
8. Chromosome 9p21 and coronary artery disease.
McPherson R
N Engl J Med; 2010 May; 362(18):1736-7. PubMed ID: 20445187
[No Abstract] [Full Text] [Related]
9. Methylation of p15INK4b and expression of ANRIL on chromosome 9p21 are associated with coronary artery disease.
Zhuang J; Peng W; Li H; Wang W; Wei Y; Li W; Xu Y
PLoS One; 2012; 7(10):e47193. PubMed ID: 23091611
[TBL] [Abstract][Full Text] [Related]
10. The 9p21 locus does not affect risk of coronary artery disease through induction of type 1 interferons.
Erridge C; Gracey J; Braund PS; Samani NJ
J Am Coll Cardiol; 2013 Oct; 62(15):1376-81. PubMed ID: 23933542
[TBL] [Abstract][Full Text] [Related]
11. Genetic variants on chromosome 9p21 and ischemic stroke in Chinese.
Hu WL; Li SJ; Liu DT; Wang Y; Niu SQ; Yang XC; Zhang Q; Yu SZ; Jin L; Wang XF
Brain Res Bull; 2009 Aug; 79(6):431-5. PubMed ID: 19559344
[TBL] [Abstract][Full Text] [Related]
12. Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk.
Burd CE; Jeck WR; Liu Y; Sanoff HK; Wang Z; Sharpless NE
PLoS Genet; 2010 Dec; 6(12):e1001233. PubMed ID: 21151960
[TBL] [Abstract][Full Text] [Related]
13. ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS.
Pasmant E; Sabbagh A; Vidaud M; Bièche I
FASEB J; 2011 Feb; 25(2):444-8. PubMed ID: 20956613
[TBL] [Abstract][Full Text] [Related]
14. Chromosome 9p21 and cardiovascular disease: the story unfolds.
Samani NJ; Schunkert H
Circ Cardiovasc Genet; 2008 Dec; 1(2):81-4. PubMed ID: 20031549
[No Abstract] [Full Text] [Related]
15. CDKN2B Regulates TGFβ Signaling and Smooth Muscle Cell Investment of Hypoxic Neovessels.
Nanda V; Downing KP; Ye J; Xiao S; Kojima Y; Spin JM; DiRenzo D; Nead KT; Connolly AJ; Dandona S; Perisic L; Hedin U; Maegdefessel L; Dalman J; Guo L; Zhao X; Kolodgie FD; Virmani R; Davis HR; Leeper NJ
Circ Res; 2016 Jan; 118(2):230-40. PubMed ID: 26596284
[TBL] [Abstract][Full Text] [Related]
16. CDKN2B gene expression is affected by 9p21.3 rs10757278 in CAD patients, six months after the MI.
Zivotić I; Djurić T; Stanković A; Milasinovic D; Stankovic G; Dekleva M; Marković Nikolić N; Alavantić D; Zivković M
Clin Biochem; 2019 Nov; 73():70-76. PubMed ID: 31386834
[TBL] [Abstract][Full Text] [Related]
17. Resequencing and clinical associations of the 9p21.3 region: a comprehensive investigation in the Framingham heart study.
Johnson AD; Hwang SJ; Voorman A; Morrison A; Peloso GM; Hsu YH; Thanassoulis G; Newton-Cheh C; Rogers IS; Hoffmann U; Freedman JE; Fox CS; Psaty BM; Boerwinkle E; Cupples LA; O'Donnell CJ
Circulation; 2013 Feb; 127(7):799-810. PubMed ID: 23315372
[TBL] [Abstract][Full Text] [Related]
18. 9p21 DNA variants associated with coronary artery disease impair interferon-γ signalling response.
Harismendy O; Notani D; Song X; Rahim NG; Tanasa B; Heintzman N; Ren B; Fu XD; Topol EJ; Rosenfeld MG; Frazer KA
Nature; 2011 Feb; 470(7333):264-8. PubMed ID: 21307941
[TBL] [Abstract][Full Text] [Related]
19. Recent studies of the human chromosome 9p21 locus, which is associated with atherosclerosis in human populations.
Holdt LM; Teupser D
Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):196-206. PubMed ID: 22258902
[TBL] [Abstract][Full Text] [Related]
20. Alu elements in ANRIL non-coding RNA at chromosome 9p21 modulate atherogenic cell functions through trans-regulation of gene networks.
Holdt LM; Hoffmann S; Sass K; Langenberger D; Scholz M; Krohn K; Finstermeier K; Stahringer A; Wilfert W; Beutner F; Gielen S; Schuler G; Gäbel G; Bergert H; Bechmann I; Stadler PF; Thiery J; Teupser D
PLoS Genet; 2013; 9(7):e1003588. PubMed ID: 23861667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
